Step Pharma is a clinical stage precision oncology company. Dencatistat (STP938) is a first in class, oral, selective CTPS1 inhibitor currently in Phase I/II clinical development in essential thrombocythemia, biomarker selected solid tumours and relapsed/refractory lymphoma.

Location

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2014
  • Number of employees in Switzerland
    1-9

Key business

Keep browsing

You may also be interested in